ENvue Medical (FEED) Cash & Equivalents Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -9.44% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 19.87% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -36.69% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 36.60% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.99% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 34.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 21.52% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -0.70% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 28.25% |
| 10 | ENvue Medical | 2.97 Mn | 709,615.89 | -55,000.00 | 13.91% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.91% |
| Dec 31, 2025 | 16.18% |
| Sep 30, 2025 | 52.40% |
| Jun 30, 2025 | 0.72% |
| Mar 31, 2025 | -53.53% |
| Dec 31, 2024 | -54.02% |
| Sep 30, 2024 | -46.66% |
| Jun 30, 2024 | -27.40% |
| Mar 31, 2024 | -30.24% |
| Dec 31, 2023 | -24.18% |
| Sep 30, 2023 | 5.98% |
| Jun 30, 2023 | 7.79% |
| Mar 31, 2023 | 153.33% |
| Dec 31, 2022 | 26.57% |
| Sep 30, 2022 | -4.41% |
| Jun 30, 2022 | 18.49% |
| Mar 31, 2022 | 219.30% |
| Dec 31, 2021 | 105.16% |
| Mar 31, 2021 | 31.58% |
| Dec 31, 2020 | 19.99% |
| Sep 30, 2020 | 238.52% |
| Jun 30, 2020 | -2.06% |
| Mar 31, 2020 | 22.17% |
| Dec 31, 2019 | 132.84% |
| Sep 30, 2019 | 61.91% |
| Jun 30, 2019 | 43.70% |
| Mar 31, 2019 | -47.59% |
| Dec 31, 2018 | -17.81% |
| Mar 31, 2018 | 7.68% |
| Dec 31, 2017 | 264.54% |
| Sep 30, 2017 | 29.22% |
| Jun 30, 2017 | 26.58% |
| Mar 31, 2017 | 11.29% |